Planet Innovation Holdings is a public unlisted, diversified technology company with a strong and profitable services business and a portfolio of strategic investments in fast-growing, global healthtech companies.
Planet Innovation exists to create breakthrough products and commercially successful businesses that transform industries and have a positive impact on the world. We focus on niche, but critical problems within large, fast growing global markets
PI’s strategy is underpinned by a two-pillar model that combines services and strategic investments to help drive commercial success and build long-term relationships with global healthtech companies.
Our Services business has delivered consistent profitability and growth since being founded in 2009. Our unique combination of end-to-end Design, Commercial, Digital and Manufacturing services have been recognized as industry leading in the development and manufacturing of innovative medical solutions. Our blend of commercial and technical services provide a strong pipeline of global opportunities that lead to recurring revenue and act as a magnet for strategic investment opportunities.
As a globally recognized healthtech innovator, Planet Innovation uses its strong industry networks, understanding of healthcare trends and deep technical insight to make strategic investments with selected partners. These investments can take the form of non-equity co-investments, minority strategic equity investments all the way through to the establishment of spin-off businesses (such as Lumos Diagnostics (ASX:LDX), Visus Therapeutics, Atmo Biosciences and Zen Ecosystems). With each strategic investment we help drive commercial success and build long term relationships with global healthtech leaders.
We apply a market-centric approach that relies on ‘market pull’ rather than ‘technology push’ when developing new products and businesses. By gathering deep market insight before building the technology solutions, we ensure there is both a customer and a market willingness to embrace the products – therefore increasing the likelihood of commercial success.